Human Epididymis Protein 4 in Women With Severe Preeclampsia / HELLP Syndrome

NCT03891394 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2019-03-28

No results posted yet for this study

Summary

Pre-eclampsia seems to be associated with a four to five times increase risk of later microalbuminuria and CKD which might suggest a possible direct renal damage from pre-eclampsia

Conditions

Interventions

DIAGNOSTIC_TEST

Human epididymis protein 4

Human epididymis protein 4 serum level in predicting persistent proteniuria

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2019-10-01
Completion
2019-10-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03891394 on ClinicalTrials.gov